His scientific interests lie mostly in Prostate cancer, Internal medicine, Gynecology, Prostatectomy and Surgery. David F. Penson has included themes like Odds ratio, Prostate and Radiation therapy in his Prostate cancer study. His biological study spans a wide range of topics, including Oncology and Risk assessment.
His Gynecology research incorporates elements of Cancer, Epidemiology, Incidence, Confidence interval and Risk factor. His studies in Prostatectomy integrate themes in fields like Urinary incontinence, Urology, Sexual function, Erectile dysfunction and Cohort. His Surgery research incorporates themes from Bladder cancer and Cystectomy.
His primary scientific interests are in Prostate cancer, Internal medicine, Oncology, Surgery and Urology. The study incorporates disciplines such as Gynecology and Prostate in addition to Prostate cancer. His Gynecology research includes themes of Odds ratio, Epidemiology, Confidence interval and Comorbidity.
His research in Oncology intersects with topics in Castration resistant and Enzalutamide. His study in Surgery is interdisciplinary in nature, drawing from both Bladder cancer and Cystectomy. His Prostatectomy research is multidisciplinary, relying on both Radiation therapy and Sexual function.
David F. Penson mainly focuses on Prostate cancer, Internal medicine, Oncology, MEDLINE and Cancer. David F. Penson interconnects Radiation therapy, Radiology and Prostate in the investigation of issues within Prostate cancer. His work on Enzalutamide, Cohort study, Androgen deprivation therapy and Quality of life as part of general Internal medicine research is frequently linked to In patient, bridging the gap between disciplines.
The various areas that David F. Penson examines in his Oncology study include Randomized controlled trial, Gynecology and Prostate cancer screening. The concepts of his Cancer study are interwoven with issues in Malignancy and Cohort. His Prostatectomy research focuses on Sexual function and how it relates to Urinary incontinence.
David F. Penson mostly deals with Prostate cancer, Internal medicine, Oncology, Prostatectomy and Cohort study. His Prostate cancer study integrates concerns from other disciplines, such as Radiation therapy and Urology. When carried out as part of a general Internal medicine research project, his work on Enzalutamide, Cohort, Randomized controlled trial and Androgen deprivation therapy is frequently linked to work in African american, therefore connecting diverse disciplines of study.
The Prostatectomy study combines topics in areas such as Interpretation, Quality of life, Sexual function, Prospective cohort study and Urinary incontinence. His work deals with themes such as Odds, Ethnic group and Proportional hazards model, which intersect with Cohort study. David F. Penson combines subjects such as Gynecology and Risk assessment with his study of Prostate-specific antigen.
This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.
Sipuleucel-T immunotherapy for castration-resistant prostate cancer.
Philip W. Kantoff;Celestia S. Higano;Neal D. Shore;E. Roy Berger.
The New England Journal of Medicine (2010)
Update on AUA Guideline on the Management of Benign Prostatic Hyperplasia
Kevin T. McVary;Claus G. Roehrborn;Andrew L. Avins;Michael J. Barry.
The Journal of Urology (2011)
Overdiagnosis Due to Prostate-Specific Antigen Screening: Lessons From U.S. Prostate Cancer Incidence Trends
Ruth Etzioni;David F. Penson;Julie M. Legler;Dante di Tommaso.
Journal of the National Cancer Institute (2002)
Early detection of prostate cancer: AUA Guideline
H. Ballentine Carter;Peter C. Albertsen;Michael J. Barry;Ruth Etzioni.
The Journal of Urology (2013)
Long-Term Functional Outcomes after Treatment for Localized Prostate Cancer
Matthew J. Resnick;Tatsuki Koyama;Kang-Hsien Fan;Peter C. Albertsen.
The New England Journal of Medicine (2013)
Five-Year Outcomes After Prostatectomy or Radiotherapy for Prostate Cancer: The Prostate Cancer Outcomes Study
Arnold L. Potosky;William W. Davis;Richard M. Hoffman;Janet L. Stanford.
Journal of the National Cancer Institute (2004)
Epidemiology and cost of ventral hernia repair: making the case for hernia research
B. K. Poulose;J. Shelton;S. Phillips;D. Moore.
5-year urinary and sexual outcomes after radical prostatectomy: results from the prostate cancer outcomes study.
David F. Penson;Dale McLerran;Ziding Feng;Lin Li.
The Journal of Urology (2005)
Overdiagnosis and Overtreatment of Prostate Cancer
Stacy Loeb;Marc A. Bjurlin;Joseph Nicholson;Teuvo L. Tammela.
European Urology (2014)
Prostate Cancer, Version 1.2016
James L. Mohler;Andrew J. Armstrong;Robert R. Bahnson;Anthony Victor D'Amico.
Journal of The National Comprehensive Cancer Network (2016)
If you think any of the details on this page are incorrect, let us know.
We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below: